Global Ulcerative Colitis Market Is Expected to Reach $10.8 Billion by 2030: Says AMR

Rise in R&D activities in the pharmaceutical & medical device industry, increase in demand for drugs required for certain treatments, and surge in adoption of various types of ulcerative colitis drugs drive the growth of the global ulcerative colitis market. Based on molecule type, the small molecules segment contributed to the major share in 2020. By region, the market across Asia-Pacific would manifest the fastest CAGR throughout the forecast period.

/EIN News/ -- Portland, OR, July 03, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Ulcerative Colitis Market was estimated at $6.2 billion in 2020 and is expected to hit $10.8 billion by 2030, registering a CAGR of 5.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and varying market trends.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/3965

Rise in R&D activities in the pharmaceutical & medical device industry, increase in demand for drugs required for certain treatments, and surge in adoption of various types of ulcerative colitis drugs drive the growth of the global ulcerative colitis market. Furthermore, surge in number of ulcerative colitis cases and emergence of key players for the development of new drugs in the medical device industry are expected to create lucrative opportunities in the industry.

Covid-19 scenario-

• Patients across the world were forced to either cancel or delay elective surgeries, including elective procedures for IBD (Inflammatory Bowel Disease). This, in turn, impacted the global ulcerative colitis market negatively.
• Also, postponement of procedures for ulcerative colitis treatment gave way to a steep decline in the production of medications for ulcerative colitis disease.

The global ulcerative colitis market is analyzed across disease type, molecule type, route of administration, and region. Based on disease type, the mild UC segment accounted for more than two-thirds of the total market share in 2020, and is expected to rule the roost by 2030. The moderate UC segment, however, would garner the fastest CAGR of 6.1% throughout the forecast period.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/3965?reqfor=covid

Based on molecule type, the small molecules segment contributed to nearly three-fourths of the total market revenue in 2020, and is projected to lead the trail by 2030. The same segment would also exhibit the fastest CAGR of 6.0% during the forecast period.

Based on region, the market across North America held the major share in 2020, garnering more than two-fifths of the global market. The Asia-Pacific region, simultaneously, would manifest the fastest CAGR of 6.5% throughout the forecast period. The report also analyzes other regions that including Europe and LAMEA.

The key market players analyzed in the global ulcerative colitis market report include Ajinomoto, AstraZeneca PLC., Eli-Lilly, GlaxoSmithKline Plc., Abbott Laboratories, Johnson & Johnson, Merck & Co., Sanofi Index Pharmaceuticals Holdings AB, and Pfizer Inc.

Report Attribute	Details
Revenue forecast in 2030	USD 10.8 billion
Growth rate	CAGR of 5.7% from 2021 to 2030
Forecast period	2020 - 2030
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Regional scope	North America, Europe, Asia Pacific, Latin America, MEA
Country scope	U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia
Key companies profiled	Abbott Laboratories, Ajinomoto, Astrazeneca Plc., Eli-Lilly, GlaxoSmithKline Plc., Index Pharmaceuticals Holdings AB, Johnson & Johnson, Merck & Co., Pfizer Inc., and Sanofi.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Immunodermatology Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Nasal Spray Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Pharmaceuticals Lipids Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Herbal Medicines Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Surgical Waste Management Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Electric Dental Handpieces Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Surgical Operating Microscope Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Radiographic Testing Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Dental Digital X-ray Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Self-Monitoring Blood Glucose Strips Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
                    
                    David Correa
                    5933 NE Win Sivers Drive
                    #205, Portland, OR 97220
                    United States
                    USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
                    UK: +44-845-528-1300
                    Hong Kong: +852-301-84916
                    India (Pune): +91-20-66346060
                    Fax: +1(855)550-5975
                    help@alliedmarketresearch.com
                    Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
                    Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/